--- title: "NEOGEN CORP (NEOG) news: class action and Nasdaq notice" url: "https://aibio.space/companies/neogen/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "NEOG class action and Nasdaq notice news: Neogen discloses appeal of dismissed Michigan securities suit and two related cases." --- NEOG NEOGEN CORP NASDAQ · United States # NEOGEN CORP (NEOG) news NEOG class action and Nasdaq notice news Legal · 2026-10-07 ## [Neogen discloses appeal of dismissed Michigan securities suit and two related cases](https://aibio.space/news/neogen-discloses-appeal-dismissed-michigan-securities-suit-two-related/) A federal court dismissed the Michigan class action with prejudice on August 10, 2026 and plaintiffs have appealed. A Minnesota Securities Act class action and a Michigan derivative suit remain pending. ## Latest NEOGEN CORP news 1. 2025-04-07 Debt Financing [Neogen refinances term loan and revolver with $450 million term loan, $250 million credit facility](https://aibio.space/news/neogen-refinances-term-loan-revolver-450-million-term-loan-250-million/) Neogen refinanced its term loan and revolving credit facility on April 4, 2025, with a new $450.0 million term loan and a $250.0 million revolver that matures April 4, 2030. The revolver had $100.0 million drawn at closing, and the company says the deal is leverage-neutral and cuts its rate, a claim the 8-K and the release do not test against the old terms. 2. 2025-01-10 Distress [Neogen files NT 10-Q late-filing notice, expects $461.4 million goodwill impairment](https://aibio.space/news/neogen-files-nt-10-q-late-filing-notice-expects-461-4-million-goodwill/) Neogen filed a late-filing notice on January 10, 2025 for its quarterly report for the quarter ended November 30, 2024. The company expects a $461.4 million goodwill impairment on its Food Safety unit and a net loss of $456.3 million, against a loss of $3.5 million a year earlier. ## NEOGEN CORP at a glance - **Ticker**: NEOG - **Listing**: NASDAQ - **Country**: United States - **Cash, Aug 31, 2026**: $172.0 million ### Related companies - [EXOZYMES INC.](https://aibio.space/companies/exozymes/) NASDAQ: EXOZ - [Bespoke Extracts](https://aibio.space/companies/bespoke-extracts/) OTC: BSPK - [Cytosorbents](https://aibio.space/companies/cytosorbents/) NASDAQ: CTSO - [NOMAD POWER SOLUTIONS, INC.](https://aibio.space/companies/nomad-power-solutions/) NASDAQ: NMAD - [Bionano Genomics](https://aibio.space/companies/bionano-genomics/) NASDAQ: BNGO - [INTELLIGENT BIO SOLUTIONS INC.](https://aibio.space/companies/intelligent-bio-solutions/) NASDAQ: INBS - [ProPhase Labs](https://aibio.space/companies/prophase-labs/) OTC: PRPH - [Cardio Diagnostics Holdings](https://aibio.space/companies/cardio-diagnostics/) NASDAQ: CDIO ### Also on NASDAQ - [PHIBRO ANIMAL HEALTH CORP](https://aibio.space/companies/phibro-animal-health/) PAHC - [National Vision Holdings](https://aibio.space/companies/national-vision/) EYE - [CG Oncology](https://aibio.space/companies/cg-oncology/) CGON - [MetaVia](https://aibio.space/companies/metavia/) MTVA - [RxSight](https://aibio.space/companies/rxsight/) RXST - [Jin Medical International](https://aibio.space/companies/jin-medical-international/) ZJYL ## What NEOGEN CORP does Neogen develops, manufactures and markets products and services dedicated to food and animal safety. Its Food Safety segment sells mainly diagnostic test kits and complementary products such as culture media to food and animal feed producers and processors, to help prevent contamination and foodborne illness and to determine food quality and nutritional components. Its Animal Safety segment develops and markets veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent and insect control products and genomics testing services. Its drug detection products are sold worldwide to detect abused and therapeutic drugs in animals and animal products, and have expanded into workplace testing and human forensic markets. In July 2025 the company divested its global Cleaners and Disinfectants business. Neogen was formed as a Michigan corporation in June 1981. Its growth strategy includes increasing sales of existing products, introducing innovative products, growing international sales, and acquiring businesses and forming strategic alliances. | Product or program | What it is | Stage | |---|---|---| | diagnostic test kits | Food safety test kits and complementary products such as culture media | | | Animal Safety segment | Veterinary instruments, pharmaceuticals, vaccines and parasiticides for animals | | | drug detection products | Detection of abused and therapeutic drugs in animals and animal products | | Summarised from the company's [10-K filed Jul 30, 2026](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/neog-20260531.htm). ## NEOGEN CORP annual financials | Line | FY ended May 31, 2026 | FY ended May 31, 2025 | |---|---|---| | Revenue | [$870.4 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | [$894.7 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | | Research and development | [$18.4 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | [$21.1 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | | Net income (loss) | [-$7.9 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | [-$1.09 billion](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | | Cash from operations | [$83.2 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | [$58.2 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | | Cash and equivalents | [$185.5 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526416954/) | [$129.0 million](https://www.sec.gov/Archives/edgar/data/711377/000119312526326092/) | | Short-term investments | | [$0](https://www.sec.gov/Archives/edgar/data/711377/000095017025100064/) | Latest balance sheet, Aug 31, 2026 (10-Q): cash and equivalents $172.0 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about NEOGEN CORP Is there a class action against NEOGEN CORP? Our latest story on this, dated Oct 7, 2026: "Neogen discloses appeal of dismissed Michigan securities suit and two related cases". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/neogen-discloses-appeal-dismissed-michigan-securities-suit-two-related/). Has NEOGEN CORP received a Nasdaq deficiency notice? Our latest story on this, dated Jan 10, 2025: "Neogen files NT 10-Q late-filing notice, expects $461.4 million goodwill impairment". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/neogen-files-nt-10-q-late-filing-notice-expects-461-4-million-goodwill/). What is the ticker symbol of NEOGEN CORP? NEOGEN CORP trades under the ticker NEOG on NASDAQ. Where is NEOGEN CORP listed? NEOGEN CORP is listed on NASDAQ. Which country or territory is NEOGEN CORP listed under? Our directory records NEOGEN CORP under United States. Does aibio.space cover NEOGEN CORP? aibio.space lists NEOGEN CORP among 2,820 public biotech companies and publishes its news here as stories appear. What does NEOGEN CORP develop? Neogen develops, manufactures and markets products and services dedicated to food and animal safety. Its Food Safety segment sells mainly diagnostic test kits and complementary products such as culture media to food and animal feed producers and processors, to help prevent contamination and foodborne illness and to determine food quality and nutritional components. What is diagnostic test kits from NEOGEN CORP? diagnostic test kits: Food safety test kits and complementary products such as culture media What is Animal Safety segment from NEOGEN CORP? Animal Safety segment: Veterinary instruments, pharmaceuticals, vaccines and parasiticides for animals What was NEOGEN CORP's revenue last year? $870.4 million for the fiscal year ended May 31, 2026, as reported to the SEC. Is NEOGEN CORP profitable? NEOGEN CORP reported a net loss of $7.9 million for the fiscal year ended May 31, 2026, and generated $83.2 million of cash from operations, per its annual report to the SEC. How much does NEOGEN CORP spend on research and development? $18.4 million in the fiscal year ended May 31, 2026, per its annual report. How much cash does NEOGEN CORP have? $172.0 million in cash at Aug 31, 2026, per its 10-Q. What is the latest NEOGEN CORP (NEOG) stock news? Our latest story on NEOGEN CORP, dated Oct 7, 2026: "Neogen discloses appeal of dismissed Michigan securities suit and two related cases". A federal court dismissed the Michigan class action with prejudice on August 10, 2026 and plaintiffs have appealed. A Minnesota Securities Act class action and a Michigan derivative suit remain pending. [Source](https://aibio.space/news/neogen-discloses-appeal-dismissed-michigan-securities-suit-two-related/). Does NEOGEN CORP have debt, a term loan or convertible notes? Our latest debt story, dated Apr 7, 2025: "Neogen refinances term loan and revolver with $450 million term loan, $250 million credit facility". Neogen refinanced its term loan and revolving credit facility on April 4, 2025, with a new $450.0 million term loan and a $250.0 million revolver that matures April 4, 2030. The revolver had $100.0 million drawn at closing, and the company says the deal is leverage-neutral and cuts its rate, a claim the 8-K and the release do not test against the old terms. [Source](https://aibio.space/news/neogen-refinances-term-loan-revolver-450-million-term-loan-250-million/). ## Investor discussion: NEOGEN CORP Members talk about NEOGEN CORP (NEOG). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:NEOG on TradingView](https://www.tradingview.com/symbols/NASDAQ-NEOG/). ## Listing details NEOGEN CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NEOG, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: NEOGEN CORP - **Ticker**: NEOG - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/neogen/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "NEOGEN CORP (NEOG) news: class action and Nasdaq notice", 2026-10-31, https://aibio.space/companies/neogen/